Buprenorphine Home Induction Tool
advertisement
| 名前 | Starting Buprenorphine |
|---|---|
| バージョン | 1.1.5 |
| アップデート | 2020年05月06日 |
| サイズ | 41 MB |
| カテゴリー | 医療 |
| インストール | 1千+ |
| 開発元 | Amston Studio |
| Android OS | Android 5.0+ |
| Google Play ID | com.amstonstudio.bup |
Starting Buprenorphine · スクリーンショット
Starting Buprenorphine · 説明
Buprenorphine Home Induction Tool (BUP) is an informative mobile application that guides patients on how to conduct Buprenorphine induction using a series of questions that the patient is asked in the mobile application.
Disclaimer:
The BUP mobile application is a tool to help those who are starting the first phase of buprenorphine treatment, the induction phase, at home. The use of this home induction app should be used in conjunction with direction and clinical support by a physician/prescriber. Using this app does not replace any discussion concerning buprenorphine use with one’s physician or provider. To achieve the best results using this application, it is recommended that information about using buprenorphine, as well as alternative options available, are discussed with one’s physician or provider. The Algorithm The algorithm that drives this app was based upon recommendations from the RAND Corporation’s SUMMIT: Procedures for Medication-Assisted Treatment of Alcohol or Opioid Dependence in Primary Care.
Thank you to our Partners:
VHA VISN 1 Innovation Grant
Theddeus Iheanacho MD
David Rosenthal MD
Josh Feler, BA, MS
Patrick Liu, BA Yale School of Medicine
Amston Studio
Love Local Design
Disclaimer:
The BUP mobile application is a tool to help those who are starting the first phase of buprenorphine treatment, the induction phase, at home. The use of this home induction app should be used in conjunction with direction and clinical support by a physician/prescriber. Using this app does not replace any discussion concerning buprenorphine use with one’s physician or provider. To achieve the best results using this application, it is recommended that information about using buprenorphine, as well as alternative options available, are discussed with one’s physician or provider. The Algorithm The algorithm that drives this app was based upon recommendations from the RAND Corporation’s SUMMIT: Procedures for Medication-Assisted Treatment of Alcohol or Opioid Dependence in Primary Care.
Thank you to our Partners:
VHA VISN 1 Innovation Grant
Theddeus Iheanacho MD
David Rosenthal MD
Josh Feler, BA, MS
Patrick Liu, BA Yale School of Medicine
Amston Studio
Love Local Design
